Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Joo-Yong Hahn, Han Cheol Lee et al.|The Lancet|2025Cited by 86
Clopidogrel Versus Aspirin Monotherapy in High-Risk Patients after Percutaneous Coronary Intervention (SMART-CHOICE 3): A Randomised, Open-Label, Multicentre TrialKi Hong Choi, anon Investigators, Yong Hwan Park et al.|SSRN Electronic Journal|2025Cited by 0
Clopidogrel vs Aspirin According to Diabetes MellitusSang Yoon Lee, Kyeong Ho Yun, Donghyeon Joo et al.|JACC: Cardiovascular Interventions|2026Cited by 0